Abstract
Although the pharmacologic effect of each of these drugs is different and directed toward various primary target tissues, all of them seem to act similarly on a
secondary target tissue, i.e., the gingival connective tissue, causing common clinical and histopathological findings.
Keywords
References
American Academy of Periodontology. Informational paper: drug associated gingival enlargement. J
Periodontol 2004;75:1424–31.
Desai P, Silver JG. Drug-induced gingival enlargements. J Can Dent Assoc 1998;64:263–8.
Brunet L, Miranda J, Farré M, Berini L, Mendieta C. Gingival enlargement induced by drugs. Drug Saf
;15:219–31.
Coletta RD, Graner E. Hereditary gingival fibromatosis: a systematic review. J Periodontol
;77:753–64.
Angelopoulos AP, Goaz PW. Incidence of diphenyl hydantoin gingival hyperplasia. Oral Surg Oral Med Oral
Pathol 1972;34:898–906.
Glickman I, Lewitus M. Hyperplasia of the gingiva associated with dilantin (sodium
diphenyl hydantoinate) therapy. J Am Dent Assoc 1941;28:1991.
Dongari-Bagtzoglou A, Research, Science and Therapy Committee, American Academy
of Periodontology. Drug-associated gingival enlargement. J Periodontol 2004;75:1424–31.
Doufexi A, Mina M, Ioannidou E. Gingival overgrowth in children: Epidemiology, pathogenesis, and
complications. A literature review. J Periodontol 2005;76:3–10.
Hallmon WW, Rossmann JA. The role of drugs in the pathogenesis of gingival overgrowth. A
collective review of current concepts. Periodontol 2000 1999;21:176–96.
Dongari-Bagtzoglou A. Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. J Periodontol 2004;75:1424–31.
Refbacks
- There are currently no refbacks.